Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Hyperplasia; Prostatic Hyperplasia Phase 2 ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms Early Phase 1 ClinicalTrials
Alzheimer Disease Phase 1/Phase 2 ClinicalTrials
CONTENTS